Of other LS spectrum cancers, bladder, ureter, kidney, and prostate cancers are more commonly associated with MSH2 defects, while cancers of the stomach, small bowel, bile duct, pancreas, and ovaries are more frequently associated with MSH2 and MLH1 defects (4). The gene discussed is MSH2; the disease is prostate carcinoma.